Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 40 Records) |
Query Trace: Abnormalities and SF3B1[original query] |
---|
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia. Haematologica 2018 9 104 (2): 360-369. Baliakas Panagiotis, Moysiadis Theodoros, Hadzidimitriou Anastasia, Xochelli Aliki, Jeromin Sabine, Agathangelidis Andreas, Mattsson Mattias, Sutton Lesley-Ann, Minga Eva, Scarfò Lydia, Rossi Davide, Davis Zadie, Villamor Neus, Parker Helen, Kotaskova Jana, Stalika Evangelia, Plevova Karla, Mansouri Larry, Cortese Diego, Navarro Alba, Delgado Julio, Larrayoz Marta, Young Emma, Anagnostopoulos Achilles, Smedby Karin E, Juliusson Gunnar, Sheehy Oonagh, Catherwood Mark, Strefford Jonathan C, Stavroyianni Niki, Belessi Chrysoula, Pospisilova Sarka, Oscier David, Gaidano Gianluca, Campo Elias, Haferlach Claudia, Ghia Paolo, Rosenquist Richard, Stamatopoulos Kostas, |
Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group. Genes, chromosomes & cancer 2018 Sep . Roos-Weil Damien, Nguyen-Khac Florence, Chevret Sylvie, Touzeau Cyrille, Roux Clémence, Lejeune Julie, Cosson Adrien, Mathis Stéphanie, Feugier Pierre, Leprêtre Stéphane, Béné Marie-Christine, Baron Marine, Raynaud Sophie, Struski Stéphanie, Eclache Virginie, Sutton Laurent, Lesty Claude, Merle-Béral Hélène, Cymbalista Florence, Ysebaert Loïc, Davi Frédéric, Leblond Véronique, |
THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT. Problemy radiatsiinoi medytsyny ta radiobiolohii 2018 Dec 23 283-301. Bilous N I, Abramenko I V, Chumak A A, Dyagil I S, Martina Z V, Saenko V, Bazyka D |
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood 2019 9 134 (21): 1821-1831. Chapiro Elise, Pramil Elodie, Diop M'boyba, Roos-Weil Damien, Dillard Clémentine, Gabillaud Clémentine, Maloum Karim, Settegrana Catherine, Baseggio Lucile, Lesesve Jean-François, Yon Mélanie, Jondreville Ludovic, Lesty Claude, Davi Frédéric, Le Garff-Tavernier Magali, Droin Nathalie, Dessen Philippe, Algrin Caroline, Leblond Véronique, Gabarre Jean, Bouzy Simon, Eclache Virginie, Gaillard Baptiste, Callet-Bauchu Evelyne, Muller Marc, Lefebvre Christine, Nadal Nathalie, Ittel Antoine, Struski Stéphanie, Collonge-Rame Marie-Agnès, Quilichini Benoit, Fert-Ferrer Sandra, Auger Nathalie, Radford-Weiss Isabelle, Wagner Lena, Scheinost Sebastian, Zenz Thorsten, Susin Santos A, Bernard Olivier A, Nguyen-Khac Florence, , |
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia. British journal of haematology 2019 6 187 (1): 82-92. Huang Ying-Jung, Kuo Ming-Chung, Chang Hung, Wang Po-Nan, Wu Jin-Hou, Huang Yen-Min, Ma Ming-Chun, Tang Tzung-Chih, Kuo Ching-Yuan, Shih Lee-Yu |
Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase. Annals of diagnostic pathology 2019 4 40 45-48. Hidalgo-Lopez Juliana E, Kanagal-Shamanna Rashmi, Reyes Steven, Zhao Chong, Medeiros L Jeffrey, Bueso-Ramos Carlos |
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 2019 Jan . Haase Detlef, Stevenson Kristen E, Neuberg Donna, Maciejewski Jaroslaw P, Nazha Aziz, Sekeres Mikkael A, Ebert Benjamin L, Garcia-Manero Guillermo, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang, Ogawa Seishi, Nagata Yasunobu, Yoshida Kenichi, Graubert Timothy A, Walter Matthew J, List Alan F, Komrokji Rami S, Padron Eric, Sallman David, Papaemmanuil Elli, Campbell Peter J, Savona Michael R, Seegmiller Adam, Adès Lionel, Fenaux Pierre, Shih Lee-Yung, Bowen David, Groves Michael J, Tauro Sudhir, Fontenay Michaela, Kosmider Olivier, Bar-Natan Michal, Steensma David, Stone Richard, Heuser Michael, Thol Felicitas, Cazzola Mario, Malcovati Luca, Karsan Aly, Ganster Christina, Hellström-Lindberg Eva, Boultwood Jacqueline, Pellagatti Andrea, Santini Valeria, Quek Lynn, Vyas Paresh, Tüchler Heinz, Greenberg Peter L, Bejar Rafael, |
Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression. Blood research 2020 8 55 (3): 131-138. Srinivasan Vishrut K, Naseem Shano, Varma Neelam, Lad Deepesh P, Malhotra Pank |
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood 2020 Mar . Tausch Eugen, Schneider Christof, Robrecht Sandra, Zhang Can, Dolnik Anna, Bloehdorn Johannes, Bahlo Jasmin, Al-Sawaf Othman, Ritgen Matthias, Fink Anna-Maria, Eichhorst Barbara, Kreuzer Karl-Anton, Tandon Maneesh, Humphrey Kathryn, Jiang Yanwen, Schary William, Bullinger Lars, Mertens Daniel, Lurà Michele Porro, Kneba Michael, Döhner Hartmut, Fischer Kirsten, Hallek Michael, Stilgenbauer Steph |
[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1. Haematologica 2020 Jan 105 (10): 2440-2447. Tausch Eugen, Beck Philipp, Schlenk Richard F, Jebaraj Billy J, Dolnik Anna, Yosifov Deyan Y, Hillmen Peter, Offner Fritz, Janssens Ann, Babu Govind K, Grosicki Sebastian, Mayer Jiri, Panagiotidis Panagiotis, McKeown Astrid, Gupta Ira V, Skorupa Alexandra, Pallaud Celine, Bullinger Lars, Mertens Daniel, Döhner Hartmut, Stilgenbauer Steph |
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia. Experimental hematology & oncology 2020 9 2. Yu Jifeng, Li Yingmei, Li Tao, Li Yafei, Xing Haizhou, Sun Hui, Sun Ling, Wan Dingming, Liu Yanfang, Xie Xinsheng, Jiang Zhongxi |
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood advances 2021 8 5 (17): 3254-3265. van der Werf Inge, Wojtuszkiewicz Anna, Meggendorfer Manja, Hutter Stephan, Baer Constance, Heymans Martijn, Valk Peter J M, Kern Wolfgang, Haferlach Claudia, Janssen Jeroen J W M, Ossenkoppele Gert J, Cloos Jacqueline, Haferlach Torst |
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. Clinical lymphoma, myeloma & leukemia 2021 11 22 (5): e293-e299. Polprasert Chantana, Niparuck Pimjai, Rattanathammethee Thanawat, Chuncharunee Suporn, Kobbuaklee Sirorat, Songserm Kritanan, Suksusut Amornchai, Trithiphen Sasinipa, Lanamtieng Theerin, Kongkiatkamon Sunisa, Chanswangphuwana Chantiya, Lawasut Panisinee, Bunworasate Udomsak, Rojnuckarin Ponlap |
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia. European journal of haematology 2021 1 106 (4): 500-507. Jajosky Audrey N, Sadri Navid, Meyerson Howard J, Oduro Kwadwo A, Kelkar Ashwin, Fitzgerald Brynn, Tomlinson Benjamin, Moore Erika M, Beck Rose |
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation. Molecular biology reports 2022 9 49 (12): 12247-12252. Bracher Susanne, Fuhrmann Irene, Jeromin Sabine, Nadarajah Niroshan, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia, Stengel An |
Genetic mutations associated with blood count abnormalities in myeloid neoplasms. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 765-771. Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlap |
Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome. British journal of haematology 2022 May . Choi Eun-Ji, Cho Young-Uk, Hur Eun-Hye, Park Han-Seung, Choi Yunsuk, Lee Jung-Hee, Lee Kyoo-Hyung, Kim Miyoung, Hwang Sang-Hyun, Jang Seongsoo, Park Chan-Jeoung, Seo Eul-Ju, Lee Je-Hw |
Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases. Blood cancer journal 2022 3 12 (3): 44. Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA. Blood advances 2022 2 6 (10): 3178-3188. Garcia-Gisbert Nieves, Garcia-Ávila Sara, Merchán Brayan, Salido Marta, Fernández-Rodríguez Concepción, Gibert Joan, Fernández-Ibarrondo Lierni, Camacho Laura, Lafuente Marta, Longarón Raquel, Espinet Blanca, Vélez Patricia, Pujol Ramon M, Andrade-Campos Marcio, Arenillas Leonor, Salar Antonio, Calvo Xavier, Besses Carles, Bellosillo Beatr |
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood cancer journal 2022 2 12 (2): 26. Mangaonkar Abhishek A, Lasho Terra L, Ketterling Rhett P, Reichard Kaaren K, Gangat Naseema, Al-Kali Aref, Begna Kebede H, Pardanani Animesh, Al Ali Najla H, Talati Chetasi, Sallman David, Padron Eric, Patnaik Mrinal M, Tefferi Ayalew, Komrokji Ra |
Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients. Cancer reports (Hoboken, N.J.) 2022 11 e1757. Sadria Reza, Motamed Nasrin, Saberi Anvar Mohammad, Mehrabani Yeganeh Hassan, Poopak Behz |
SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis. Leukemia 2022 Oct . Huber Sandra, Haferlach Torsten, Meggendorfer Manja, Hutter Stephan, Hoermann Gregor, Baer Constance, Kern Wolfgang, Haferlach Claud |
Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations. In vivo (Athens, Greece) 2023 4 37 (3): 985-993. Jinming Song, Lynn Moscinski, Ethan Yang, Haipeng Shao, Mohammad Hussaini, Hailing Zha |
MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations. International journal of molecular sciences 2023 2 24 (4): . Ahn Ari, Kim Hoon Seok, Kim Tong-Yoon, Lee Jong-Mi, Kang Dain, Yu Haein, Lee Chae Yeon, Kim Yonggoo, Eom Ki-Seong, Kim Myungsh |
The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms. Leukemia research 2023 12 136 107433. Vishesh Khanna, Rong Lu, Jyoti Kumar, Alfonso Molina, Henning Stehr, Elizabeth Spiteri, Michael Spinner, Oscar Silva, Sebastian Fernandez-Pol, Brent Tan, Peter L Greenbe |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: